1 The retractions came only weeks after BioMed Central.

But that move might not be enough, as the publisher Hindawi discovered this past spring. Although Hindawi doesn’t let authors recommend reviewers for their manuscripts, it decided to examine the peer-review records for manuscripts submitted in 2013 and 2014 for possible fraud. The peer-review procedure used in Hindawi’s journals depends mainly on the expertise of its editorial board members and the guest editors of special issues, who are in charge of supervising the overview of submitted manuscripts.5 Because the peer reviewers selected by the guest editors weren’t subject to any kind of independent verification, editors themselves could undermine the procedure in much the same way that authors or third-party agencies have done somewhere else: by creating fake reviewer identities and addresses from which they submitted positive reviews endorsing publication.The investigators advise that any individuals transplanted with a kidney which includes stones must have close follow up with tests focused on kidney stone detection. In addition they advise that the patient should be vigilant in looking out for rock obstruction symptoms like nausea and vomiting; bloody, cloudy or foul-smelling urine; or a persistent desire to urinate. The Mayo research was undertaken due to lack of published literature relating to long-term outcomes with transplanting kidneys that have stones. One out of 10 Us citizens develops kidney stones. Ten % of these with kidney stones don’t have symptoms.

Affibody, GE Health care partner to develop Her2-targeted PET imaging agent GE Health care signed an agreement with Affibody AB to collaborate on the advancement of a Her2-targeted PET imaging agent, which is scheduled to begin with clinical trials later this season.